---
document_datetime: 2023-09-21 21:49:54
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/dasatinib-accordpharma-epar-all-authorised-presentations_en.pdf
document_name: dasatinib-accordpharma-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 3.0227586
conversion_datetime: 2025-12-20 11:58:59.953295
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name                  | Strength   | Pharmaceutical Form        | Route of Administration   | Immediate Packaging          | Pack size                  |
|------------------|----------------------------------|------------|----------------------------|---------------------------|------------------------------|----------------------------|
| EU/1/21/1541/001 | Dasatinib Accordpharma           | 20 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu) authorised | 56 tablets                 |
| EU/1/21/1541/002 | Dasatinib Accordpharma           | 20 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 60 tablets                 |
| EU/1/21/1541/003 | Dasatinib Accordpharma           | 20 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 56 x 1 tablets (unit dose) |
| EU/1/21/1541/004 | Dasatinib Accordpharma           | 20 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 60 x 1 tablets (unit dose) |
| EU/1/21/1541/005 | Dasatinib Accordpharma           | 50 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 56 tablets                 |
| EU/1/21/1541/006 | Dasatinib Accordpharma           | 50 mg      | Film-coated tablet         | Oral use longer           | blister (alu/alu)            | 60 tablets                 |
| EU/1/21/1541/007 | Dasatinib Accordpharma           | 50 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 56 x 1 tablets (unit dose) |
| EU/1/21/1541/008 | Dasatinib Accordpharma           | 50 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 60 x 1 tablets (unit dose) |
| EU/1/21/1541/009 | Dasatinib Accordpharma           | 70 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 56 tablets                 |
| EU/1/21/1541/010 | Dasatinib Accordpharma           | 70 mg      | Film-coated tablet no      | Oral use                  | blister (alu/alu)            | 60 tablets                 |
| EU/1/21/1541/011 | Dasatinib Accordpharma           | 70 mg      | Film-coated tablet product | Oral use                  | blister (alu/alu)            | 56 x 1 tablets (unit dose) |
| EU/1/21/1541/012 | Dasatinib Accordpharma           | 70 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 60 x 1 tablets (unit dose) |
| EU/1/21/1541/013 | Dasatinib Accordpharma           | 80 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 30 tablets                 |
| EU/1/21/1541/014 | Dasatinib Accordpharma           | 80 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 56 tablets                 |
| EU/1/21/1541/015 | Dasatinib Accordpharma           | 80 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 30 x 1 tablets (unit dose) |
| EU/1/21/1541/016 | Dasatinib Accordpharma           | 80 mg      | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 56 x 1 tablets (unit dose) |
| EU/1/21/1541/017 | Dasatinib Accordpharma           | 100 mg     | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 30 tablets                 |
| EU/1/21/1541/018 | Dasatinib Accordpharma Medicinal | 100 mg     | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 56 tablets                 |
| EU/1/21/1541/019 | Dasatinib Accordpharma           | 100 mg     | Film-coated tablet         | Oral use                  | blister (alu/alu)            | 30 x 1 tablets (unit dose) |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented)             | Strength   | Pharmaceutical     | Route of       | Immediate                    | Pack size                  |
|------------------|------------------------|------------|--------------------|----------------|------------------------------|----------------------------|
|                  | name                   |            | Form               | Administration | Packaging                    |                            |
| EU/1/21/1541/020 | Dasatinib Accordpharma | 100 mg     | Film-coated tablet | Oral use       | blister (alu/alu) authorised | 56 x 1 tablets (unit dose) |
| EU/1/21/1541/021 | Dasatinib Accordpharma | 140 mg     | Film-coated tablet | Oral use       | blister (alu/alu)            | 30 tablets                 |
| EU/1/21/1541/022 | Dasatinib Accordpharma | 140 mg     | Film-coated tablet | Oral use       | blister (alu/alu)            | 56 tablets                 |
| EU/1/21/1541/023 | Dasatinib Accordpharma | 140 mg     | Film-coated tablet | Oral use       | blister (alu/alu)            | 30 x 1 tablets (unit dose) |
| EU/1/21/1541/024 | Dasatinib Accordpharma | 140 mg     | Film-coated tablet | Oral use       | blister (alu/alu)            | 56 x 1 tablets (unit dose) |

<!-- image -->